Anti-migraine drugs in development: advances in serotonin receptor pharmacology.
Humphrey
P P
PP
Pharmacology Division, Glaxo Group Research Limited, Ware, Hertfordshire, U.K.
Feniuk
W
W
Perren
M J
MJ
D000818:Animals; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004341:Drug Evaluation; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D008881:Migraine Disorders / Q000188:drug therapy*; D011985:Receptors, Serotonin / Q000187:drug effects*; D013449:Sulfonamides / Q000494:pharmacology*; D018170:Sumatriptan; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D007211:Indoles; D011985:Receptors, Serotonin; D013449:Sulfonamides; D014662:Vasoconstrictor Agents; D018170:Sumatriptan